2005Testowy IndexCopernicusRequires access

Molecular Mechanisms of Erythromycin Resistance in Mycoplasma Pneumonia

Deli Xin

Open publisher page 2 citations

Abstract

Objective To study erythromycin resistance and determine molecular mechanisms in mycoplasma pneumoniae.Methods Sixty clinical samples were cultured, drug sensitive test was done to identify resistant strain, and then drug-resistant gene was screened.Results Five clinical strains were isolated from 60 samples. Among them four strains were resistant to erythromycin and the percentage was 80%. The 23 S rRNA gene sequences of the susceptible strain and the reference strain were identical to mycoplasma pneumoniae gene in genebank. While four resistant strains had a point mutation respectively, two had A to G transition at position 2063, the other two had A to G transition at position 2064 . None of the five strains had erm gene.Conclusions There is erythromycin resistance in mycoplasma pneumoniae and the molecular mechanism is point mutation in 23 S rRNA, erythromycin ribosomal methylase gene erm gene isn′t founded.

About this research paper

What this paper is about

Objective To study erythromycin resistance and determine molecular mechanisms in mycoplasma pneumoniae.Methods Sixty clinical samples were cultured, drug sensitive test was done to identify resistant strain, and then drug-resistant gene was screened.Results Five clinical strains were isolated from 60 samples. Among them four strains were resistant to erythromycin and the percentage was 80%. The 23 S rRNA gene sequences of the susceptible strain and the reference strain were identical to mycoplasma pneumoniae gene in genebank. While four resistant strains had a point mutation respectively, two had A to G transition at position 2063, the other two had A to G transition at position 2064 . None of the five strains had erm gene.Conclusions There is erythromycin resistance in mycoplasma pneumoniae and the molecular mechanism is point mutation in 23 S rRNA, erythromycin ribosomal methylase gene erm gene isn′t founded.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study erythromycin resistance and determine molecular mechanisms in mycoplasma pneumoniae.Methods Sixty clinical samples were cultured, drug sensitive test was done to identify resistant strain, and then drug-resistant gene was screened.Results Five clinical strains were isolated from 60 samples. Among them four strains were resistant to erythromycin and the percentage was 80%. The 23 S rRNA gene sequences of the susceptible strain and the reference strain were identical to mycoplasma pneumoniae gene in genebank. While four resistant strains had a point mutation respectively, two had A to G transition at position 2063, the other two had A to G transition at position 2064 . None of the five strains had erm gene.Conclusions There is erythromycin resistance in mycoplasma pneumoniae and the molecular mechanism is point mutation in 23 S rRNA, erythromycin ribosomal methylase gene erm gene isn′t founded.

Key concepts: Erythromycin, Mycoplasma pneumoniae, Microbiology, 23S ribosomal RNA, Biology, Point mutation, Drug resistance, Gene

Related papers

Back to paper searchBrowse research topicsOriginal source
Molecular Mechanisms of Erythromycin Resistance in Mycoplasma Pneumonia — Research Paper | ScholarLens